Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in polymeric gene delivery systems.

Khursheed Anwer1, B G Rhee, Sanjeev Kumar Mendiratta

  • 1Expression Genetics, Inc., Huntsville, Alabama 35801, USA. kanwer@egencorp.com

Critical Reviews in Therapeutic Drug Carrier Systems
|November 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findings.

Expert opinion on investigational drugs·2026
Same author

Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 study.

Vaccine·2026
Same author

Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].

Gynecologic oncology·2025
Same author

Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2.

Frontiers in immunology·2025
Same author

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.

Gynecologic oncology·2025
Same author

Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer.

Vaccine·2024

Advancements in polymeric gene delivery systems offer safer, more efficient alternatives to viral vectors. Their adaptable nature and cost-effectiveness pave the way for clinical gene therapy applications.

Area of Science:

  • Biomaterials Science
  • Gene Therapy
  • Nanotechnology

Background:

  • First-generation polymers have been superseded by advanced, functionalized polymeric gene delivery systems.
  • Molecular functionalization enhances biocompatibility, stability, cell-specificity, and intracellular trafficking of gene carriers.
  • Polymeric carriers are transitioning from in vitro studies to preclinical validation in disease models.

Purpose of the Study:

  • To review the progress and potential of polymeric gene delivery systems.
  • To highlight improvements in safety and efficiency through molecular functionalization.
  • To discuss the future clinical translation and commercialization of these systems.

Main Methods:

  • Review of recent literature on polymeric gene delivery systems.

Related Experiment Videos

  • Analysis of molecular functionalization strategies for improved performance.
  • Evaluation of preclinical data in disease models (cancer, diabetes, cardiovascular disorders).

    • Main Results:

    • Significant improvements in polymer biocompatibility, stability, and targeting.
    • Successful preclinical validation in various disease models.
    • Polymeric carriers show promise despite lower transfection efficiency than viral vectors.

    Conclusions:

    • Polymeric gene delivery systems are evolving towards safer and more efficient therapeutic options.
    • Structural flexibility allows for continuous performance enhancement.
    • Cost-effective manufacturing and scale-up may overcome current performance gaps, leading to clinical adoption.